7D7W image
Entry Detail
PDB ID:
7D7W
Keywords:
Title:
Crystal Structure of the Domain1 of NAD+ Riboswitch with nicotinamide adenine dinucleotide (NAD+)
Biological Source:
Source Organism:
PDB Version:
Deposition Date:
2020-10-06
Release Date:
2020-11-25
Method Details:
Experimental Method:
Resolution:
2.39 Å
R-Value Free:
0.23
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
I 2 2 2
Macromolecular Entities
Polymer Type:polyribonucleotide
Description:18GAAA (52-MER)
Chain IDs:A
Chain Length:51
Number of Molecules:1
Biological Source:synthetic construct
Primary Citation
Structural distinctions between NAD+ riboswitch domains 1 and 2 determine differential folding and ligand binding.
Nucleic Acids Res. 48 12394 12406 (2020)
PMID: 33170270 DOI: 10.1093/nar/gkaa1029

Abstact

Riboswitches are important gene regulatory elements frequently encountered in bacterial mRNAs. The recently discovered nadA riboswitch contains two similar, tandemly arrayed aptamer domains, with the first domain possessing high affinity for nicotinamide adenine dinucleotide (NAD+). The second domain which comprises the ribosomal binding site in a putative regulatory helix, however, has withdrawn from detection of ligand-induced structural modulation thus far, and therefore, the identity of the cognate ligand and the regulation mechanism have remained unclear. Here, we report crystal structures of both riboswitch domains, each bound to NAD+. Furthermore, we demonstrate that ligand binding to domain 2 requires significantly higher concentrations of NAD+ (or ADP retaining analogs) compared to domain 1. Using a fluorescence spectroscopic approach, we further shed light on the structural features which are responsible for the different ligand affinities, and describe the Mg2+-dependent, distinct folding and pre-organization of their binding pockets. Finally, we speculate about possible scenarios for nadA RNA gene regulation as a putative two-concentration sensor module for a time-controlled signal that is primed and stalled by the gene regulation machinery at low ligand concentrations (domain 1), and finally triggers repression of translation as soon as high ligand concentrations are reached in the cell (domain 2).

Legend

Protein

Chemical

Disease

Primary Citation of related structures